Dr. Ferrario graduated in 2001 and completed his residency in Medical Oncology in 2005 at the University of Milan, Italy.

After a period of training at the Istituto Nazionale Tumori in Milan, Dr Ferrario moved to Montreal (Canada) to work as a visiting scientist in basic research at the Lady Davis Institute for two years.

In 2007 he was awarded the Terry Fox Foundation Post MD Research Fellowship Award and completed a 4-year clinical fellowship program at the Oncology Department of McGill University. During this time he worked in clinical research in breast, hepatobiliary and prostate cancers.

In 2011 he moved back to Italy where he worked for two years as a medical oncologist at the “IRST” (Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori) in Meldola, focusing on breast cancer and on the treatment of refractory testicular cancer with high-dose chemotherapy.

In 2012 he accepted a position as Assistant Professor in the Oncology Department of McGill University (Montreal) and Medical Oncologist at the Segal Cancer Centre (Jewish General Hospital, Montreal), where he is currently working. He treats breast and urological cancers and is particularly dedicated to clinical research, being currently involved in several phase 1-3 clinical trials.

In 2012 he was the recipient of the Kate McGarrigle Fellowship Award. In 2014 the Faculty of Medicine of McGill University awarded him with the Introduction to Clinical Medicine Oncology Award for Excellence in Teaching.